David Lau
Scientist
Jonathan Cebon Lab Ludwig Center at Melbourne
Ludwig Institute for Cancer Research
Switzerland
Biography
In addition to participation in melanoma and hepatoma cancer clinics, my principal responsibilities involve the management of patients in early phase clinical trials with oncological malignancy: protocol development, regulatory affairs, trial conduct in line with GCP, and all aspects of clinical and administrative management and reporting. My translational research interests involve: • Clinical trials evaluating targeted biologic agents, particularly early phase trials with targeted antibodies. • Development of investigator-initiated clinical trial concepts • Application of immunotherapies and cancer vaccines to clinical trials
Research Interest
Melanoma and hepatoma cancer, clinical trials,immunotherapy
Publications
-
Genest, Jacques, et al. "2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult–2009 recommendations." Canadian Journal of Cardiology 25.10 (2009): 567-579.
-
Rucker, Diana, et al. "Long term pharmacotherapy for obesity and overweight: updated meta-analysis." Bmj 335.7631 (2007): 1194-1199.
-
Meltzer, Sara, et al. "1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association." CMAJ: Canadian Medical Association journal= journal de l'Association medicale canadienne 159 (1998): S1-29.
